Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jagpreet Chhatwal

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Plos One|November 13, 2012
What is the optimal threshold at which to recommend breast biopsy?Elizabeth S Burnside, Jagpreet Chhatwal, Oguzhan Alagoz
Journal of Gastroenterology and Hepatology|June 5, 2018
Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatmentAmit Goel, Qiushi Chen, Jagpreet Chhatwal, et al.
Pharmacoeconomics|January 11, 2016
Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting AntiviralsJagpreet Chhatwal, Tianhua He, Maria A Lopez-Olivo
Cancer|August 8, 2015
Reply to price and value in cancer careJagpreet Chhatwal, Michael S Mathisen, Hagop M Kantarjian
The American Journal of Gastroenterology|July 18, 2023
The Rising Costs of Alcohol-Associated Liver Disease in the United StatesJovan Julien, Turgay Ayer, Elliot B Tapper, et al.
Liver Cancer|December 17, 2024
Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with CirrhosisAmit G Singal, Jagpreet Chhatwal, Neehar Parikh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2017
Reply to C. Nabhan et alQiushi Chen, Nitin Jain, Christopher R Flowers, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
ReplyJagpreet Chhatwal, Sumeyye Samur, Emily Bethea, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 22, 2016
Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-SavingJagpreet Chhatwal, Tianhua He, Chin Hur, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 3, 2017
ReplySumeyye Samur, Emily D Bethea, Raymond T Chung, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Plos One|November 13, 2012
What is the optimal threshold at which to recommend breast biopsy?Elizabeth S Burnside, Jagpreet Chhatwal, Oguzhan Alagoz
Journal of Gastroenterology and Hepatology|June 5, 2018
Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatmentAmit Goel, Qiushi Chen, Jagpreet Chhatwal, et al.
Pharmacoeconomics|January 11, 2016
Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting AntiviralsJagpreet Chhatwal, Tianhua He, Maria A Lopez-Olivo
Cancer|August 8, 2015
Reply to price and value in cancer careJagpreet Chhatwal, Michael S Mathisen, Hagop M Kantarjian
The American Journal of Gastroenterology|July 18, 2023
The Rising Costs of Alcohol-Associated Liver Disease in the United StatesJovan Julien, Turgay Ayer, Elliot B Tapper, et al.
Liver Cancer|December 17, 2024
Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with CirrhosisAmit G Singal, Jagpreet Chhatwal, Neehar Parikh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2017
Reply to C. Nabhan et alQiushi Chen, Nitin Jain, Christopher R Flowers, et al.
Hepatology (Baltimore, Md.)|June 7, 2017
ReplyJagpreet Chhatwal, Sumeyye Samur, Emily Bethea, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 22, 2016
Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-SavingJagpreet Chhatwal, Tianhua He, Chin Hur, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 3, 2017
ReplySumeyye Samur, Emily D Bethea, Raymond T Chung, et al.
Pageof 17